|
Methylene blue (antidote) 5 mg/ml intravenous solution
|
$2,170.71 |
$2,170.71 |
$2,170.71 |
$1,132.12
|
|
Methylnaltrexone 12 mg/0.6 ml subcutaneous injection (wrapper)
|
$1,969.03 |
$1,969.03 |
$1,969.03 |
$493.10
|
|
Methylprednisolone acetate 40 mg/ml suspension for injection
|
$176.93 |
$176.93 |
$176.93 |
$63.05
|
|
Metoclopramide in d5w IV syringe 0.2 mg/ml (neo/ped) - cnr
|
$109.06 |
$109.06 |
$109.06 |
$30.75
|
|
Metronidazole 500 mg/100 ml in sodium chlor(iso) intravenous piggyback
|
$116.37 |
$116.37 |
$116.37 |
$48.03
|
|
Midazolam 1 mg/ml injection solution
|
$426.35 |
$426.35 |
$426.35 |
$75.79
|
|
Midazolam 1 mg/ml in sodium chloride IV infusion (wrapper)
|
$1,099.86 |
$1,099.86 |
$1,099.86 |
$126.10
|
|
Milrinone 20 mg/100 ml(200 mcg/ml) in 5 % dextrose intravenous piggybk
|
$245.52 |
$245.52 |
$245.52 |
$101.22
|
|
Mirvetuximab soravtansine-gynx 5 mg/ml intravenous solution
|
$5,837.22 |
$5,837.22 |
$5,837.22 |
$4,875.39
|
|
Mitomycin 40 mg intravenous solution
|
$3,065.05 |
$3,065.05 |
$3,065.05 |
$1,650.98
|
|
Monovisc inj per dose
|
$7,288.35 |
$7,288.35 |
$7,288.35 |
$2,476.72
|
|
Mopath procedure level 3
|
$3,001.35 |
$3,001.35 |
$3,001.35 |
$341.30
|
|
Morphine 4 mg/ml injection (wrapper)
|
$818.03 |
$818.03 |
$818.03 |
$60.61
|
|
Morphine 4 mg/ml injection (wrapper)|discarded drug not administered
|
$117.35 |
$117.35 |
$117.35 |
$39.99
|
|
Morphometric analysis in situ hybridization computer-assisted per specimen each multiplex stain
|
$2,743.40 |
$2,743.40 |
$2,743.40 |
$402.00
|
|
Morphometric analysis tumor ihc qn/sq per specimen each single antibody stain manual
|
$2,743.40 |
$2,743.40 |
$2,743.40 |
$309.50
|
|
M/phmtrc alys ishquant/semiq
|
$2,743.40 |
$2,743.40 |
$2,743.40 |
$574.00
|
|
Mpl gene analysis common variants
|
$636.66 |
$636.66 |
$636.66 |
$444.00
|
|
Mr safety determination physician/other qhp
|
$295.04 |
$295.04 |
$295.04 |
$160.20
|
|
Mr safety implant elec prepj
|
$309.28 |
$309.28 |
$309.28 |
$168.60
|
|
Mr safety implt pos&/immoblj
|
$196.49 |
$196.49 |
$196.49 |
$137.25
|
|
Mr sfty implt&/fb asmt stf 1
|
$82.38 |
$82.38 |
$82.38 |
$45.00
|
|
Mr sfty med physics xm cstmz
|
$812.98 |
$812.98 |
$812.98 |
$402.40
|
|
Mumps antibody igg
|
$260.55 |
$260.55 |
$260.55 |
$78.00
|
|
Mycophenolate mofetil 250 mg capsule
|
$753.20 |
$753.20 |
$753.20 |
$18.12
|
|
Mycoplasma antibody igm
|
$264.34 |
$264.34 |
$264.34 |
$79.20
|
|
Myeloperoxidase ab multi step qualitative/semiquantitative
|
$230.21 |
$230.21 |
$230.21 |
$134.40
|
|
Nalbuphine 10 mg/ml injection solution
|
$120.53 |
$120.53 |
$120.53 |
$38.00
|
|
Nasal endoscopy with removal of nasal foreign body
|
$4,204.23 |
$4,204.23 |
$4,204.23 |
$691.35
|
|
Natalizumab 300 mg/15 ml intravenous solution
|
$98,610.49 |
$98,610.49 |
$98,610.49 |
$22,257.60
|
|
Natriuretic peptide
|
$390.60 |
$390.60 |
$390.60 |
$176.15
|
|
Ndl insj without njx 1 or 2 musc
|
$501.52 |
$501.52 |
$501.52 |
$43.00
|
|
Neck (Cervical Spine) CT scan (with and without contrast)
|
$2,710.26 |
$2,710.26 |
$2,710.26 |
$2,055.15
|
|
Neck (Cervical Spine) CT scan (with contrast)
|
$5,897.27 |
$5,897.27 |
$5,897.27 |
$1,766.05
|
|
Neck (Cervical Spine) CT scan (without contrast)
|
$11,470.36 |
$11,470.36 |
$11,470.36 |
$1,513.95
|
|
Neostigmine methylsulfate 1 mg/ml injection (wrapper)
|
$205.17 |
$205.17 |
$205.17 |
$56.70
|
|
Neuroeltrd stim post tibial
|
$3,712.85 |
$3,712.85 |
$3,712.85 |
$478.14
|
|
Nicardipine 25 mg/10 ml intravenous solution
|
$1,303.10 |
$1,303.10 |
$1,303.10 |
$356.09
|
|
Nitroglycerin 50 mg/250 ml (200 mcg/ml) in 5 % dextrose intravenous
|
$24.19 |
$24.19 |
$24.19 |
$65.30
|
|
Nivolumab 10 mg/ml intravenous solution (wrapper)
|
$54,969.07 |
$54,969.07 |
$54,969.07 |
$17,658.98
|
|
Nivolumab 240 mg-relatlimab-rmbw 80 mg/20 ml intravenous solution
|
$263,782.46 |
$263,782.46 |
$263,782.46 |
$85,051.55
|
|
Nudt15 gene common variants
|
$5,817.00 |
$5,817.00 |
$5,817.00 |
$320.50
|
|
Obinutuzumab 1,000 mg/40 ml intravenous solution
|
$9,950.46 |
$9,950.46 |
$9,950.46 |
$14,996.94
|
|
Observation direct referral from physician office for admission
|
$2,244.79 |
$2,244.79 |
$2,244.79 |
$411.10
|
|
Ocrelizumab 30 mg/ml intravenous solution
|
$512,927.10 |
$512,927.10 |
$512,927.10 |
$54,942.65
|
|
Octreotide acetate 100 mcg/ml injection (wrapper)
|
$234.35 |
$234.35 |
$234.35 |
$73.13
|
|
Ofatumumab 20 mg/ml intravenous solution (wrapper)
|
$100,255.74 |
$100,255.74 |
$100,255.74 |
$5,346.32
|
|
Omalizumab 150 mg/ml subcutaneous syringe (wrapper)
|
$35,208.84 |
$35,208.84 |
$35,208.84 |
$4,797.94
|
|
Oncology prostate prob score
|
$15,173.40 |
$15,173.40 |
$15,173.40 |
$1,048.80
|
|
Oncoprotein dcp
|
$1,285.96 |
$1,285.96 |
$1,285.96 |
$167.75
|
|
Ondansetron hcl (pf) 2 mg/ml injection (wrapper)
|
$83.10 |
$83.10 |
$83.10 |
$34.32
|
|
Organic acids total quant ea spec
|
$471.17 |
$471.17 |
$471.17 |
$151.36
|
|
Orphenadrine citrate 30 mg/ml injection solution
|
$183.46 |
$183.46 |
$183.46 |
$65.07
|
|
Ortho hnd/fngr without jnt cstm w/fit&adj
|
$1,740.09 |
$1,740.09 |
$1,740.09 |
$213.39
|
|
Ortho hnd/fngr w/jnt cstm w/fit&adj
|
$1,650.76 |
$1,650.76 |
$1,650.76 |
$389.25
|
|
Orthovisc inj per dose
|
$1,431.52 |
$1,431.52 |
$1,431.52 |
$498.00
|
|
Ortho whf rigd without jnt cstm w/fit&adj
|
$2,145.84 |
$2,145.84 |
$2,145.84 |
$269.58
|
|
Oscillation chest wall mechanical per session
|
$605.19 |
$605.19 |
$605.19 |
$221.34
|
|
Osmolality blood
|
$164.81 |
$164.81 |
$164.81 |
$67.60
|
|
Osmolality urine
|
$193.94 |
$193.94 |
$193.94 |
$65.65
|
|
Ot evaluation high complexity patient/family
|
$1,113.08 |
$1,113.08 |
$1,113.08 |
$303.05
|
|
Ot evaluation low complexity patient/family
|
$1,113.08 |
$1,113.08 |
$1,113.08 |
$238.00
|
|
Ot evaluation moderate complexity patient/family
|
$1,113.08 |
$1,113.08 |
$1,113.08 |
$270.58
|
|
Ot management orthotic(s)/prosthetic subsequent encounter each 15 minutes
|
$190.34 |
$190.34 |
$190.34 |
$100.75
|
|
Ot management/training orthotic(s) upper/lower extremities and/or trunk each 15 minutes
|
$528.28 |
$528.28 |
$528.28 |
$107.40
|
|
Ot manual therpy techniques >=1 region each 15 minutes
|
$271.00 |
$271.00 |
$271.00 |
$107.32
|
|
Ot re-evaluation patient/family
|
$392.73 |
$392.73 |
$392.73 |
$174.00
|
|
Ot therapeutic activities direct patient contact each 15 minutes
|
$240.88 |
$240.88 |
$240.88 |
$100.20
|
|
Ot therapeutic interventions cognitive skills direct patient contact each additional 15 minutes
|
$213.33 |
$213.33 |
$213.33 |
$87.00
|
|
Ot therapeutic interventions cognitive skills direct patient contact initial 15 minutes
|
$234.49 |
$234.49 |
$234.49 |
$91.80
|
|
Ot therapeutic procedure >=1 area therapeutic exercise each 15 minutes
|
$326.25 |
$326.25 |
$326.25 |
$97.80
|
|
Ot therapeutic procedure neuromuscular reeducate each 15 minutes
|
$329.13 |
$329.13 |
$329.13 |
$100.10
|
|
Ot training self care/home management direct contact each 15 minutes
|
$321.02 |
$321.02 |
$321.02 |
$93.75
|
|
Oxaliplatin 5 mg/ml desensitization
|
$789.57 |
$789.57 |
$789.57 |
$364.29
|
|
Paclitaxel 6 mg/ml concentrate,intravenous
|
$2,788.22 |
$2,788.22 |
$2,788.22 |
$231.46
|
|
Palonosetron hcl
|
$3,514.44 |
$3,514.44 |
$3,514.44 |
$372.41
|
|
Pamidronate 30 mg/10 ml (3 mg/ml) intravenous solution
|
$504.31 |
$504.31 |
$504.31 |
$146.80
|
|
Panitumumab 20 mg/ml intravenous solution (wrapper)
|
$58,586.11 |
$58,586.11 |
$58,586.11 |
$18,554.59
|
|
Pantoprazole in ns IV syringe 0.8 mg/ml (neo/ped) - cnr
|
$188.18 |
$188.18 |
$188.18 |
$44.25
|
|
Papaverin hcl injection
|
$266.05 |
$266.05 |
$266.05 |
$76.40
|
|
Parathormone (pth) intact
|
$459.80 |
$459.80 |
$459.80 |
$200.23
|
|
Pegfilgrastim 6 mg/0.6 ml (deliverable) wearable subcutaneous injector
|
$58,917.79 |
$58,917.79 |
$58,917.79 |
$12,556.80
|
|
Pegfilgrastim-apgf 6 mg/0.6 ml subcutaneous syringe
|
$20,656.81 |
$20,656.81 |
$20,656.81 |
$7,670.65
|
|
Pegfilgrastim-cbqv 6 mg/0.6 ml subcutaneous syringe
|
$41,525.38 |
$41,525.38 |
$41,525.38 |
$8,382.81
|
|
Pegfilgrastim-jmdb 6 mg/0.6 ml subcutaneous syringe
|
$21,999.71 |
$21,999.71 |
$21,999.71 |
$5,908.68
|
|
Pelvic CT scan (with contrast)
|
$2,710.26 |
$2,710.26 |
$2,710.26 |
$1,669.00
|
|
Pelvic CT scan (without contrast)
|
$8,564.41 |
$8,564.41 |
$8,564.41 |
$1,332.80
|
|
Pelvic Ultrasound (complete)
|
$3,268.09 |
$3,268.09 |
$3,268.09 |
$643.80
|
|
Pelvic Ultrasound (limited)
|
$2,213.93 |
$2,213.93 |
$2,213.93 |
$445.00
|
|
Pembrolizumab 25 mg/ml intravenous solution
|
$102,918.06 |
$102,918.06 |
$102,918.06 |
$16,340.69
|
|
Penicillin g benzathine 1,200,000 unit/2 ml intramuscular syringe
|
$7,714.55 |
$7,714.55 |
$7,714.55 |
$643.59
|
|
Penile vascular study
|
$2,213.93 |
$2,213.93 |
$2,213.93 |
$460.20
|
|
Perflutren lipid microspheres 1.1 mg/ml intravenous suspension
|
$565.95 |
$565.95 |
$565.95 |
$321.71
|
|
Pericardial drain w/cath pq w/ct guid
|
$1,493.38 |
$1,493.38 |
$1,493.38 |
$2,816.25
|
|
Pertuzumab 30 mg/ml desensitization
|
$59,526.87 |
$59,526.87 |
$59,526.87 |
$18,443.20
|
|
Pertuzu, trastuzu, 10 mg
|
$151,736.15 |
$151,736.15 |
$151,736.15 |
$41,963.08
|
|
Ph body fluid
|
$71.48 |
$71.48 |
$71.48 |
$39.20
|
|
Phenobarbital in ns IV syringe 10 mg/ml (neonate) - cnr
|
$767.57 |
$767.57 |
$767.57 |
$123.17
|
|
Phenobarbital therapeutic drug level
|
$310.43 |
$310.43 |
$310.43 |
$104.50
|
|
Phenylephrine 10 mg/ml injection solution
|
$173.78 |
$173.78 |
$173.78 |
$58.49
|